Study Raises Concerns About Prostate Cancer Screening in Transgender Women
A recent study led by the University of California – San Francisco has raised concerns about the interpretation of standard prostate cancer screening guidelines for transgender women. Transgender women on hormone therapy may show artificially low results on PSA tests, potentially delaying the detection and treatment of prostate cancer. Specific PSA ranges tailored to this population are needed to address the unique challenges faced by transgender women in prostate cancer screening.
Study Finds Disproportionately High Rates of HIV Among Transgender Women, Particularly Those from Marginalized Racial and Ethnic Groups
Transgender women, particularly those from marginalized racial and ethnic groups, have been found to have disproportionately high rates of HIV, according to a new study by the Centers for Disease Control and Prevention (CDC). The study, published in the CDC’s…